ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study

BACKGROUND: The ExtaviJect® 30G autoinjector was developed to facilitate parenteral self-administration of interferon beta-1b (Extavia®), a first-line disease-modifying therapy in patients with multiple sclerosis. Our aim was to assess patient compliance with treatment when using the autoinjector, p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Boeru, Gabriel, Milanov, Ivan, De Robertis, Francesca, Kozubski, Wojciech, Lang, Michael, Rojas-Farreras, Sònia, Tomlinson, Mark
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2013
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3832381/
https://ncbi.nlm.nih.gov/pubmed/24255602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/MDER.S52590
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados